Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
DEI Quote, Financials, Valuation and Earnings
Last price:
$18.08
Seasonality move
:
-1.29%
Day range:
$17.78 - $18.69
52-week range:
$12.36 - $20.50
Dividend yield:
4.2%
P/E ratio:
--
P/S ratio:
3.02x
P/B ratio:
1.45x
Volume:
5.8M
Avg. volume:
1.4M
1-year change:
19.1%
Market cap:
$3B
Revenue:
$1B
EPS (TTM):
-$0.10
Earnings Data
Next earnings date for DEI
Feb 07
2025
Most recent earnings per share
$0.03
Beat by $0.03
(Nov 4/2024)
Consensus Estimate
-$0.00
(Nov 4/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DEI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/07/2025 | Q4 | $242.6M | -- | -- | -$0.05 | -- |
| 11/04/2024 | Q3 | $244.9M | $250.8M | $0.03 | -$0.00 | $0.03 |
| 08/08/2024 | Q2 | $247.2M | $245.8M | $0.06 | $0.02 | $0.04 |
| 05/08/2024 | Q1 | $251.8M | $245M | $0.05 | -$0.11 | $0.16 |
| 02/06/2024 | Q4 | $252.8M | $259.3M | -$0.24 | -$0.10 | -$0.14 |
| 10/31/2023 | Q3 | -- | -- | -$0.08 | -$0.08 | -$0.00 |
| 08/01/2023 | Q2 | -- | -- | -$0.04 | $0.09 | -$0.13 |
| 05/02/2023 | Q1 | -- | -- | $0.10 | $0.10 | $0.00 |
| 02/07/2023 | Q4 | -- | -- | $0.14 | $0.13 | $0.01 |
| 11/03/2022 | Q3 | -- | -- | $0.13 | $0.13 | $0.00 |
| 08/01/2022 | Q2 | -- | -- | $0.14 | $0.14 | $0.00 |
| 05/03/2022 | Q1 | -- | -- | $0.14 | $0.12 | $0.02 |
| 02/08/2022 | Q4 | -- | -- | $0.11 | $0.10 | $0.01 |
| 11/02/2021 | Q3 | -- | -- | $0.10 | $0.06 | $0.04 |
| 08/03/2021 | Q2 | -- | -- | $0.09 | $0.05 | $0.04 |
| 05/04/2021 | Q1 | -- | -- | $0.06 | $0.02 | $0.04 |
| 02/09/2021 | Q4 | -- | -- | $0.10 | $0.04 | $0.06 |
| 11/02/2020 | Q3 | -- | -- | $0.02 | $0.01 | $0.01 |
| 08/06/2020 | Q2 | -- | -- | $0.01 | $0.11 | -$0.10 |
| 05/07/2020 | Q1 | -- | -- | $0.15 | $0.05 | $0.10 |
| 02/11/2020 | Q4 | -- | -- | $1.58 | $0.15 | $1.43 |
| 11/05/2019 | Q3 | -- | -- | $0.13 | $0.15 | -$0.02 |
| 08/05/2019 | Q2 | -- | -- | $0.20 | $0.17 | $0.03 |
| 05/02/2019 | Q1 | -- | -- | $0.17 | $0.12 | $0.05 |
| 02/12/2019 | Q4 | -- | -- | $0.15 | $0.18 | -$0.03 |
| 11/01/2018 | Q3 | -- | -- | $0.18 | $0.18 | $0.00 |
| 07/31/2018 | Q2 | -- | -- | $0.19 | $0.17 | $0.02 |
| 05/08/2018 | Q1 | -- | -- | $0.17 | $0.17 | $0.00 |
| 02/13/2018 | Q4 | -- | -- | $0.17 | $0.17 | -$0.00 |
| 11/07/2017 | Q3 | -- | -- | $0.15 | $0.15 | $0.01 |
| 08/01/2017 | Q2 | -- | -- | $0.13 | $0.13 | -$0.00 |
| 05/02/2017 | Q1 | -- | -- | $0.12 | $0.13 | -$0.00 |
| 02/07/2017 | Q4 | -- | -- | $0.47 | $0.45 | $0.02 |
| 11/01/2016 | Q3 | -- | -- | $0.47 | $0.45 | $0.02 |
| 08/02/2016 | Q2 | -- | -- | $0.46 | $0.45 | $0.01 |
| 05/04/2016 | Q1 | -- | -- | $0.43 | $0.42 | $0.01 |
| 02/10/2016 | Q4 | -- | -- | $0.41 | $0.41 | -- |
| 11/03/2015 | Q3 | -- | -- | $0.40 | $0.40 | -- |
| 08/04/2015 | Q2 | -- | -- | $0.40 | $0.40 | -- |
| 05/05/2015 | Q1 | -- | -- | $0.43 | $0.42 | $0.01 |
| 02/10/2015 | Q4 | -- | -- | $0.39 | $0.39 | -- |
Douglas Emmett Earnings Questions
-
How Much did Douglas Emmett Generate in Revenue Last Quarter?
Douglas Emmett reported $250.8M worth of top line sales in its most recent quarter.
-
Did Douglas Emmett Beat Earnings Last Quarter?
Douglas Emmett announced earnings per share of $0.03 which represents a beat of analyst forecast a -$0.00 per share.
-
Is Douglas Emmett Profitable?
Douglas Emmett reported $156M that represents $0.93 per share over the last quarter.
-
What is the Analyst Consensus for Douglas Emmett EPS Next Year?
Douglas Emmett's earnings are forecast to decrease from -$0.26 per share to -$0.11 per share next year representing a decrease of -96.58%.
-
When is Douglas Emmett's Earnings Date?
Douglas Emmett's next earnings date is February 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
